1. Neuralstem Announces the Appointment of Two New Members to the Board of Directors

    Neuralstem Announces the Appointment of Two New Members to the Board of Directors

    (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Zhang Zhuo and Cristina Csimma, PharmD, MHP, have been appointed to its Board of Directors, effective September 18, 2017...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. I'm very pleased to welcome Mr. Zhang and Dr. Csimma to our Board.
    2. Dr. Csimma brings with her decades of senior leadership experience in the biopharmaceutical industry as well as a wealth of expertise in drug development. Her insights into corporate operations and capital raising will be immensely helpful to Neuralstem during this potentially transformative period for the company.
  3. Topics Mentioned

  4. Authors